Clinically important effect sizes for clinical trials using infarct growth reduction as the primary outcome: a systematic review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinically important effect sizes for clinical trials using infarct growth reduction as the primary outcome: a systematic review
Authors
Keywords
-
Journal
Journal of NeuroInterventional Surgery
Volume -, Issue -, Pages jnis-2023-020850
Publisher
BMJ
Online
2023-11-01
DOI
10.1136/jnis-2023-020850
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimum important difference is minimally important in sample size calculations
- (2023) Hubert Wong Trials
- Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
- (2023) Wenjie Zi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke
- (2023) Hyo Suk Nam et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Challenge of Designing Stroke Trials That Change Practice: MCID vs. Sample Size and Pragmatism
- (2022) Mayank Goyal et al. Journal of Stroke
- Time to recognize three classes of non-inferiority trial margins
- (2022) Jeffrey L Saver et al. Journal of NeuroInterventional Surgery
- Early and Delayed Infarct Growth in Patients Undergoing Mechanical Thrombectomy: A Prospective, Serial MRI Study
- (2022) María Hernández-Pérez et al. STROKE
- The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
- (2021) Matthew J. Page et al. PLOS MEDICINE
- Predictors of Early and Late Infarct Growth in DEFUSE 3
- (2021) William J. Tate et al. Frontiers in Neurology
- Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
- (2020) Michael D Hill et al. LANCET
- Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
- (2019) Henry Ma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Noninferiority Margins in Trials of Thrombectomy Devices for Acute Ischemic Stroke
- (2019) Chun-Jen Lin et al. STROKE
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
- (2018) Gregory W. Albers et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
- (2018) Raul G. Nogueira et al. NEW ENGLAND JOURNAL OF MEDICINE
- DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
- (2018) Jonathan A Cook et al. BMJ-British Medical Journal
- Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies
- (2017) Jessica S. Cranston et al. STROKE
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
- (2015) Jeffrey L. Saver et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
- (2015) Bruce C.V. Campbell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minimal Clinically Important Difference
- (2014) Anna E. McGlothlin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now